Granalix is planning a clinical trial for MS patients in which GranaGard will be administered in addition to conventional drugs.
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidantArticle, , Published articles, 0
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system and is associated with demyelination, neurodegeneration,...
Pomegranate seed oil nanoemulsions for the prevention and treatment ofneurodegenerative diseases: the case of genetic CJDArticle, , Published articles, 0
Neurodegenerative diseases generate the accumulation of specific misfolded proteins, such as PrPSc prions or A-beta in Alzheimer’s diseases, and...